Accendra Health — Third Quarter 2026 Earnings Summary

Accendra Health reported a net loss of $19.7 million for the third quarter of 2026, driven by a decline in net revenue to $601.8 million from $697.3 million in the prior year period. The company's year-to-date loss from continuing operations widened to $113.5 million as of September 30, 2026, compared to $93.2 million in the same period of 2025. Management indicated that full-year 2026 net revenue is expected to fall at the bottom of the previous guidance range, with adjusted EBITDA potentially dropping by up to 30% from prior expectations. The company is currently executing a turnaround strategy aimed at restoring profitability and has outlined a value creation plan to address key operational challenges.